UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------
SCHEDULE 13G
(Amendment No. __)
Under the Securities Exchange Act of 1934
Pharmacyclics Inc.
--------------------------------------------
(Name of issuer)
Common Stock
--------------------------------------------
(Title of class of securities)
716933106
--------------------------------------------
(CUSIP number)
May 17, 2000
--------------------------------------------
(Date of Event which requires filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this schedule is filed:
/_/ Rule 13d-1 (b)
/X/ Rule 13d-1 (c)
/_/ Rule 13d-1 (d)
<PAGE>
- ---------------------------------
CUSIP No. 716933106 13G
- ---------------------------------
- -------- -----------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Deutsche Bank A.G.
- -------- -----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) /_/
(b) /_/
- -------- -----------------------------------------------------------------------
3 SEC USE ONLY
- -------- -----------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Federal Republic of Germany
- ---------------------------- ------ --------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 0
BENEFICIALLY ------ --------------------------------------------
OWNED BY SHARED VOTING POWER
EACH 6 792,000
REPORTING ------ --------------------------------------------
PERSON SOLE DISPOSITIVE POWER
WITH 7 0
------ --------------------------------------------
SHARED DISPOSITIVE POWER
8 792,000
- -------- -----------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
792,000
- -------- -----------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES /_/
- -------- -----------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.2%
- -------- -----------------------------------------------------------------------
12 TYPE OF REPORTING PERSON
HC, BK, CO
- -------- -----------------------------------------------------------------------
<PAGE>
Item 1(a). Name of Issuer:
Pharmacyclics Inc. (the "Issuer")
Item 1(b). Address of Issuer's Principal Executive Offices:
The address of the Issuer's principal executive offices is 995
East Arques Avenue, Sunnyvale, California 94086-4521, USA.
Item 2(a). Name of Person Filing:
This statement is filed on behalf of Deutsche Bank AG ( the
"Reporting Person").
Item 2(b). Address of Principal Business Office or, if none, Residence:
The principal place of business of the Reporting Person is
Taunusanlage 12, D-60325, Frankfurt am Main, Federal Republic of Germany.
Item 2(c). Citizenship:
The citizenship of the Reporting Person is set forth on the cover
page.
Item 2(d). Title of Class of Securities:
The title of the securities is Common Stock (the "Common
Stock").
Item 2(e). CUSIP Number:
The CUSIP number of the Common Stock is set forth on the cover
page.
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b) or (c), check whether the person filing is a:
(a) /_/ Broker or dealer registered under section 15 of the
Act;
(b) /_/ Bank as defined in section 3(a)(6) of the Act;
(c) /_/ Insurance Company as defined in section 3(a)(19) of
the Act;
(d) /_/ Investment Company registered under section 8 of the
Investment Company Act of 1940;
(e) /_/ An investment adviser in accordance with Rule 13d-1
(b)(1)(ii)(E);
(f) /_/ An employee benefit plan, or endowment fund in
accordance with Rule 13d-1 (b)(1)(ii)(F);
(g) /_/ A parent holding company or control person in
accordance with Rule 13d-1 (b)(1)(ii)(G);
(h) /_/ A savings association as defined in section 3(b) of
the Federal Deposit Insurance Act;
(i) /_/ A church plan that is excluded from the
definition of an investment company under section
3(c)(14) of the Investment Company Act of 1940;
(j) /_/ Group, in accordance with Rule 13d-1 (b)(1)(ii)(J).
If this statement is filed pursuant to Rule 13d-1 (c), check this
box. /X/
Item 4. Ownership.
(a) Amount beneficially owned:
The Reporting Person owns the amount of the Common Stock as set forth
on the cover page.
(b) Percent of class:
The Reporting Person owns the percentage of the Common Stock as set
forth on the cover page.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
The Reporting Person has the sole power to vote or direct the
vote of the Common Stock as set forth on the cover page.
(ii) shared power to vote or to direct the vote:
The Reporting Person has the shared power to vote or direct the
vote of the Common Stock as set forth on the cover page.
(iii) sole power to dispose or to direct the disposition of:
The Reporting Person has the sole power to dispose or direct the
disposition of the Common Stock
as set forth on the cover page.
(iv) shared power to dispose or to direct the disposition of:
The Reporting Person has the shared power to dispose or direct
the disposition of the Common Stock as set forth on the cover page.
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Investment management clients of the Reporting Person's subsidiaries
have the ultimate right to dividends from Common Stock held on their behalf and
the proceeds from the sale of Common Stock held on their behalf.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company.
The following are subsidiaries of the Reporting Person which hold
Common Stock included in the figures on the cover pages: Deutsche Fonds Holding
GmbH, Deutsche Gesellschaft fur Wertpapiersparen mbH, Deutsche
Vermogensbildungsgesellschaft mbh, DWS Investment Management S.A. Luxemburg and
Deutsche Asset Management Investmentgesellschaft GmbH.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: May 25, 2000
DEUTSCHE BANK AG
By: /s/ Christoph Kirschhofer
-------------------------------------
Name: Christoph Kirschhofer
Title: Director
By: /s/ Dr. Rainer Grimberg
------------------------------------
Name: Dr. Rainer Grimberg
Title: Director
